NO20061937L - Utvidet trefaseprevansjonskur - Google Patents

Utvidet trefaseprevansjonskur

Info

Publication number
NO20061937L
NO20061937L NO20061937A NO20061937A NO20061937L NO 20061937 L NO20061937 L NO 20061937L NO 20061937 A NO20061937 A NO 20061937A NO 20061937 A NO20061937 A NO 20061937A NO 20061937 L NO20061937 L NO 20061937L
Authority
NO
Norway
Prior art keywords
extended
progestin
estrogen
days
administered
Prior art date
Application number
NO20061937A
Other languages
English (en)
Inventor
Katherine D Laguardia
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20061937L publication Critical patent/NO20061937L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Det beskrives et forlenget trefase oralt kontraseptivregime. I henhold til det beskrevne regime blir en kombinasjon av et østrogen og et progestin administrert i minst 42 på hverandre følgende dager, etterfulgt av en hormonfri periode på fra 4 til 8 dager. Østrogen og progestin administreres i en kontraseptivt effektiv, daglig dose i en sekvens på minst to sykler på minst 21 dager, der østrogendoseringen forblir konstant over hver syklus og progestindoseringen økes i tre faser over hver syklus.
NO20061937A 2003-10-01 2006-05-02 Utvidet trefaseprevansjonskur NO20061937L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50753603P 2003-10-01 2003-10-01
PCT/US2004/032497 WO2005032558A1 (en) 2003-10-01 2004-09-30 Extended triphasic contraceptive regimens

Publications (1)

Publication Number Publication Date
NO20061937L true NO20061937L (no) 2006-06-29

Family

ID=34421627

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061937A NO20061937L (no) 2003-10-01 2006-05-02 Utvidet trefaseprevansjonskur

Country Status (14)

Country Link
US (1) US20050090475A1 (no)
EP (1) EP1673094A1 (no)
JP (1) JP2007507534A (no)
KR (1) KR20060129175A (no)
CN (1) CN1863537A (no)
AU (1) AU2004277998A1 (no)
BR (1) BRPI0414945A (no)
CA (1) CA2540697A1 (no)
CO (1) CO5690602A2 (no)
NO (1) NO20061937L (no)
NZ (1) NZ545969A (no)
RU (1) RU2006114791A (no)
WO (1) WO2005032558A1 (no)
ZA (1) ZA200603416B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
NZ591627A (en) 2001-12-05 2012-09-28 Teva Womens Health Inc Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
EP1624848A4 (en) 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE
NZ545130A (en) 2003-07-16 2009-03-31 Duramed Pharmaceuticals Inc Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
MX2007004120A (es) * 2004-10-07 2007-06-15 Duramed Pharmaceuticals Inc Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente.
CA2640520C (en) * 2006-03-02 2014-04-22 Warner Chilcott Company, Inc. Extended cycle multiphasic oral contraceptive method

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US36247A (en) * 1862-08-19 Improvement in car-couplings
US4264575A (en) * 1979-07-16 1981-04-28 Eli Lilly And Company Contraceptive methods and compositions
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
DE3929376C1 (no) * 1989-09-05 1991-04-18 E.I. Du Pont De Nemours And Co., Wilmington, Del., Us
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5439913A (en) * 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US6451778B1 (en) * 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US6479475B1 (en) * 1996-07-26 2002-11-12 Wyeth Oral contraceptive
DE19705229C2 (de) * 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
JP2001513566A (ja) * 1997-08-27 2001-09-04 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 経口避妊における、エストロゲンと子宮内膜節約性プロゲスチンおよび子宮内膜萎縮性プロゲスチンとの組み合わせ物
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6326392B1 (en) * 1997-11-06 2001-12-04 American Home Products Corporation Anti-estrogen plus progestin containing oral contraceptives
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6329416B1 (en) * 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US20020177580A1 (en) * 2001-05-23 2002-11-28 Van Beek Agatha Antonia Magdalena Means and method for hormonal contraception
US20030018018A1 (en) * 2001-07-10 2003-01-23 Medical College Of Hampton Roads Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea

Also Published As

Publication number Publication date
EP1673094A1 (en) 2006-06-28
RU2006114791A (ru) 2007-11-27
CO5690602A2 (es) 2006-10-31
JP2007507534A (ja) 2007-03-29
WO2005032558A1 (en) 2005-04-14
CN1863537A (zh) 2006-11-15
KR20060129175A (ko) 2006-12-15
CA2540697A1 (en) 2005-04-14
BRPI0414945A (pt) 2006-11-07
US20050090475A1 (en) 2005-04-28
AU2004277998A1 (en) 2005-04-14
ZA200603416B (en) 2007-09-26
NZ545969A (en) 2008-07-31

Similar Documents

Publication Publication Date Title
ES2558030T3 (es) Método anticonceptivo oral multifásico de ciclo prolongado
AR024566A1 (es) Administracion de esteroides androgenicos no orales a mujeres
FI970260A7 (fi) Progesteroniantagonisti ja gestageeni endometrioosin ja leiomyomata uterin hoitamiseksi
CY1108990T1 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
NO986104D0 (no) Progesteron-anti-progesteron regimer
CO5251419A1 (es) Composiciones nanoparticuladas de eplerenona
NO923874L (no) Ovulasjonshemmende middel for hormonell antikonsepsjon
BR9916579A (pt) Contraceptivo oral trifásico
NO982902L (no) FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen
CA2542854A1 (en) Graduated estrogen contraceptive
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
NO20061937L (no) Utvidet trefaseprevansjonskur
AR051931A1 (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes
HUP9900612A2 (hu) Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra
NO20072893L (no) Fast, peroralt prevensjonsmiddel
CY1111406T1 (el) Χρηση βαλερικης οιστραδιολης ή οιστραδιολης σε συνδυασμο με διενογεστη για την απο του στοματος θεραπεια της αιμορραγιας λογω δυσλειτουργιας της μητρας με τη μορφη απο του στοματος αντισυλληψης
WO2005092441A3 (en) Extended cycle multiphasic oral contraceptive method
NO20072687L (no) Farmasoytisk prevensjonspreparat
PE20000887A1 (es) Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo
CY1112775T1 (el) Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος
RU2009140372A (ru) Новый режим с дроспиреноном/17b-эстрадиолом, фармацевтический комбинированный продукт и набор для выполнения этого режима
ECSP993262A (es) Nuevos regimen anticonceptivo
TH84327B (th) การใช้และชุดสำเร็จรูปแอนโดรเจนสเตอรอยด์ (Androgenic Steriod) แบบที่ไม่ใช้รับประทานในสุภาพสตรี

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application